Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Breo ellipta inhaler price?Is there a generic for ozempic pen?Is there a generic for trelegy ellipta?Nexletol 180 mg price?When does ozempic go generic?
See the DrugPatentWatch profile for Icosapent
Icosapent ethyl is marketed under the brand name VASCEPA.
It is used as a therapy to help reduce cardiovascular risk in certain adults, typically in combination with other risk-management approaches, depending on the specific indication and patient profile.
VASCEPA is developed and marketed by Amarin Pharma in the U.S.
In the U.S., the primary branded form of icosapent ethyl is VASCEPA. Generic versions, if approved and marketed, would use the nonproprietary name “icosapent ethyl.”
For patent and exclusivity tracking related to icosapent ethyl (VASCEPA), see DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Icosapent :